626 Giochiamo: Giochiamo 626 - Gaming for Health and Security in Workerplaces

Sponsor
Universitas Mercatorum (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06060379
Collaborator
University of Roma La Sapienza (Other)
60
2
7

Study Details

Study Description

Brief Summary

The aim of the "626 Giochiamo" project is to realise and evaluate the effectiveness of a training course involving the use of games, which helps to convey the basic principles of health and safety in the workplace.

Condition or Disease Intervention/Treatment Phase
  • Other: GiochiAMO a 626
N/A

Detailed Description

The seminar on health and safety in the workplace and basic principles will be presented to the recruited workers. At the end of the intervention they will be divided into two groups: the control group and the intervention group. The intervention group will be involved in a meeting dedicated to games in three different types, board, card and role-playing games.

A questionnaire on occupational health and safety knowledge will be administered to all study participants before the seminar (T=0), after the seminar (T=1) and after the intervention group has played (T=2).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The trial consists of three meetings. In the first meeting all enrolled participants will take part in a seminar. Before the seminar starts and at the end, a questionnaire will be administered to them to investigate their prior and acquired knowledge on the subject. At the end the participants will be divided into two groups, the control group will not participate in the second phase, the intervention group will be invited to a game meeting. The third meeting will take place days later, where the third and final game will be conducted with the intervention group. At the end of the game, the questionnaire will be administered.The trial consists of three meetings. In the first meeting all enrolled participants will take part in a seminar. Before the seminar starts and at the end, a questionnaire will be administered to them to investigate their prior and acquired knowledge on the subject. At the end the participants will be divided into two groups, the control group will not participate in the second phase, the intervention group will be invited to a game meeting. The third meeting will take place days later, where the third and final game will be conducted with the intervention group. At the end of the game, the questionnaire will be administered.
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Giochiamo 626 - Gaming for Health and Security in Workerplaces
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention gruop

Partecipant will participate in playful encounters

Other: GiochiAMO a 626
The subjects of the intervention group will play three different games: a role-playing game, a card game and a board game.

No Intervention: Control group

Subjects will not partecipate in the games

Outcome Measures

Primary Outcome Measures

  1. The percentage of knowledge increased as a result of participation in the games [Participants are assessed by means of a questionnaire administered at the beginning of the trial (t=0), one day after the seminar (t=1) and after one month (t=2).]

    Effectiveness is understood as acquiring and increasing knowledge of key concepts on safety in the workplace, the roles of key persons who can influence health and safety, and the tools available for evaluation and monitoring.

Eligibility Criteria

Criteria

Ages Eligible for Study:
17 Years to 69 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
Exclusion Criteria:
  • No worker

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Universitas Mercatorum
  • University of Roma La Sapienza

Investigators

  • Principal Investigator: Alice Mannocci, Universitas Mercatorum

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Alice Mannocci, Professor, Universitas Mercatorum
ClinicalTrials.gov Identifier:
NCT06060379
Other Study ID Numbers:
  • 6-FIN/RIC2023
First Posted:
Sep 29, 2023
Last Update Posted:
Sep 29, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Alice Mannocci, Professor, Universitas Mercatorum

Study Results

No Results Posted as of Sep 29, 2023